Huang, Bo <br/><br/>
Quantitative decision-making in randomized Phase II studies with a time-to-event endpoint.  [electronic resource] 

 -  Journal of biopharmaceutical statistics  2019 
 - 189-202 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1520-5711 
<br/><br/><label>Standard No.: </label>10.1080/10543406.2018.1489400  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biostatistics--methods<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>Clinical Trials, Phase II as Topic--statistics & numerical data<br/>Clinical Trials, Phase III as Topic--statistics & numerical data<br/>Data Interpretation, Statistical<br/>Decision Making<br/>Endpoint Determination--statistics & numerical data<br/>Humans<br/>Pancreatic Neoplasms--drug therapy<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Research Design--statistics & numerical data<br/>Time Factors<br/>Treatment Outcome